Chemistry and pharma Fault-tolerant quantum computing 'will solve exciting science problems' Quantinuum’s Dr Harry Buhrman and Russell Stutz discuss the technological innovation underpinning the company’s development of fault-tolerant quantum computing systems Latest Content Meta and VSParticle launch catalyst database to accelerate transition to clean energy UK National Quantum lab will open up access to quantum computing in the UK Optibrium demonstrates molecular docking method for small molecules and macrocycles New technologies QC Ware launches Promethium for chemical and materials discovery PhoreMost enhances drug discovery process Optibrium appoints Dr Hamed Tabatabaei Ghomi as Head of Research White papers Leveraging open platforms for scalable quantum computing control systems Quantum computing is complicated, but the infrastructure doesn’t have to be Understanding compound selectivity with data-driven drug design Selectivity is a crucial property in the development of new active pharmaceutical ingredients (APIs). Reducing Risk & Improving Synthesis Outcomes with SYNTHIA Retrosynthesis Software Addressing the many intrinsic and external challenges to chemical synthesis has led to a highly complex system of regulations that invo Webcasts Free Energy Perturbation: How Computational Chemistry Saves Time In Drug Discovery From Data Silos to Data Flow: Unlocking Your Lab with the Right ELN A Cautionary Tale for AI in Small Molecule Drug Discovery More content Transforming the future of virtual research with contract organisations How a methods database increases lab efficiency Creating better treatments with AI Nvidia BioNeMo enables generative AI for drug discovery AI shapes the future of precision medicine The latest software products for QA/QC in 2023 Pocket-sized DNA sequencers track malaria drug resistance in near real-time Pistoia Alliance sets out its strategy to accelerate sustainability and the adoption of AI £225m investment aims to put the UK at the “forefront of the AI revolution” The low-code/no-code revolution and data management Case study: How AstraZeneca is overcoming obstacles to analytical data access Democratising access to medicine with AI Pagination Previous page ‹ Previous Page 4 Next page Next ›